These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6425067)

  • 21. [Cellular immunity in chronic polyarthritis: the effect of basic therapy on T-lymphocyte subpopulations].
    Rosenthal M; Sendelova S
    Schweiz Med Wochenschr; 1983 Mar; 113(11):394-8. PubMed ID: 6221406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-lymphocyte subsets in pleural fluids: discrimination according to traditional and monoclonal antibody-defined markers.
    Kochman S; Bernard J; Lavaud F; Cazabat A; Dubois de Montreynaud JM
    Eur J Respir Dis; 1984 Nov; 65(8):586-91. PubMed ID: 6240409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoregulatory changes in autoimmune disease.
    Veys EM; Hermanns P; Verbruggen G; Mielants H
    Diagn Immunol; 1983; 1(3):224-32. PubMed ID: 6238752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical relevance of determining lymphocyte subpopulations in peripheral blood of patients with rheumatoid arthritis].
    Hempel M; Wietschel F; Malberg K; Kästner P
    Allerg Immunol (Leipz); 1989; 35(3):187-93. PubMed ID: 2573260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of T lymphocyte subsets in human colostrum.
    Richie ER; Bass R; Meistrich ML; Dennison DK
    J Immunol; 1982 Sep; 129(3):1116-9. PubMed ID: 6980919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T lymphocytic subpopulations of normal human peripheral blood defined by monoclonal antibodies: an ultrastructural study using immunogold staining method.
    Cinti S; Balercia G; Canon C; Dantchev D; Mathé G
    Basic Appl Histochem; 1986; 30(1):41-52. PubMed ID: 2424426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auranofin: more than just oral gold.
    Waller ES
    Clin Pharm; 1984; 3(2):195. PubMed ID: 6426845
    [No Abstract]   [Full Text] [Related]  

  • 32. [Basic therapy of rheumatoid arthritis with auranofin].
    Goebel KM
    Dtsch Med Wochenschr; 1985 Jan; 110(2):64-5. PubMed ID: 3917898
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T lymphocyte subpopulations in progressive systemic sclerosis defined by monoclonal antibodies.
    Czirják L; Surányi P; Dankó K; Szegedi G
    Acta Med Hung; 1985; 42(3-4):129-32. PubMed ID: 3879347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral gold approved for some arthritis patients.
    FDA Drug Bull; 1985 Aug; 15(2):15-6. PubMed ID: 3932112
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of lymphocyte subpopulations in patients with bladder cancer: a study with monoclonal antibodies.
    Morita T; Yonese Y; Minato N
    Hinyokika Kiyo; 1987 Jun; 33(6):838-43. PubMed ID: 3499769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
    Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
    J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibody-defined T-cell surface phenotypes in human breast milk.
    Bertotto A; Gentili F; Vaccaro R
    Boll Ist Sieroter Milan; 1983 Sep; 62(4):370-1. PubMed ID: 6607056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.